SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-021962
Filing Date
2023-08-03
Accepted
2023-08-03 16:25:48
Documents
88
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20230630_10q.htm   iXBRL 10-Q 2299047
2 EXHIBIT 10.1 ex_547923.htm EX-10.1 1225989
3 EXHIBIT 31.1 ex_519394.htm EX-31.1 12385
4 EXHIBIT 31.2 ex_519395.htm EX-31.2 12308
5 EXHIBIT 32.1 ex_519396.htm EX-32.1 3888
6 EXHIBIT 32.2 ex_519397.htm EX-32.2 3793
12 x01.jpg GRAPHIC 5014
  Complete submission text file 0001437749-23-021962.txt   13308665

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA opk-20230630.xsd EX-101.SCH 90240
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20230630_cal.xml EX-101.CAL 72506
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20230630_def.xml EX-101.DEF 755744
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20230630_lab.xml EX-101.LAB 581189
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20230630_pre.xml EX-101.PRE 783526
82 EXTRACTED XBRL INSTANCE DOCUMENT opk20230630_10q_htm.xml XML 2148864
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 231140477
SIC: 2834 Pharmaceutical Preparations